APO Research
Talk to an analyst

APO RESEARCH · REPORT

Esketamine Hydrochloride Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Esketamine Hydrochloride Injection Industry Growth and Trends Forecast to 2032

27 December 202579 pages

Choose your research edition.

Industry ResearchEsketamine Hydrochloride Injection Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Esketamine Hydrochloride Injection Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Esketamine Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Esketamine Hydrochloride Injection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Esketamine Hydrochloride Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Esketamine Hydrochloride Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Esketamine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Esketamine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Esketamine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Esketamine Hydrochloride Injection include Jiangsu Hengrui Medicine, Pfizer and Laboratoires CDM Lavoisier, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Esketamine Hydrochloride Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Esketamine Hydrochloride Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Esketamine Hydrochloride Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Esketamine Hydrochloride Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Esketamine Hydrochloride Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Esketamine Hydrochloride Injection Market by Company

Jiangsu Hengrui Medicine

Pfizer

Laboratoires CDM Lavoisier

Esketamine Hydrochloride Injection Segment by Type

2ml:50mg

5ml:25mg

Others

Esketamine Hydrochloride Injection Segment by Application

Hospitals and Clinics

Ambulatory Surgery Centers

Esketamine Hydrochloride Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Esketamine Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Esketamine Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Esketamine Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Esketamine Hydrochloride Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Esketamine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 2ml:50mg Table 2. Major Company of 5ml:25mg Table 3. Major Company of Others Table 4. Global Esketamine Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 6. Global Esketamine Hydrochloride Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Esketamine Hydrochloride Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Esketamine Hydrochloride Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Esketamine Hydrochloride Injection Sales by Type (2027-2032) & (K Units) Table 11. Global Esketamine Hydrochloride Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Esketamine Hydrochloride Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Esketamine Hydrochloride Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Esketamine Hydrochloride Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 16. North America Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 18. Europe Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 22. Latin America Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Esketamine Hydrochloride Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Esketamine Hydrochloride Injection Industry Trends Table 26. Esketamine Hydrochloride Injection Industry Drivers Table 27. Esketamine Hydrochloride Injection Industry Opportunities and Challenges Table 28. Esketamine Hydrochloride Injection Industry Restraints Table 29. Global Esketamine Hydrochloride Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Esketamine Hydrochloride Injection Revenue Market Share by Company (2021-2026) Table 31. Global Esketamine Hydrochloride Injection Sales by Company (2021-2026) & (K Units) Table 32. Global Esketamine Hydrochloride Injection Sales Share by Company (2021-2026) Table 33. Global Esketamine Hydrochloride Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Esketamine Hydrochloride Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Esketamine Hydrochloride Injection Major Company Production Sites and Headquarters Table 36. Global Esketamine Hydrochloride Injection Company, Product Type & Application Table 37. Global Esketamine Hydrochloride Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Esketamine Hydrochloride Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Esketamine Hydrochloride Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Esketamine Hydrochloride Injection Sales by Region (2021-2026) & (K Units) Table 42. Global Esketamine Hydrochloride Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Esketamine Hydrochloride Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Esketamine Hydrochloride Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Esketamine Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Esketamine Hydrochloride Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Esketamine Hydrochloride Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Esketamine Hydrochloride Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Esketamine Hydrochloride Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Esketamine Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Esketamine Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Esketamine Hydrochloride Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Esketamine Hydrochloride Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Esketamine Hydrochloride Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Esketamine Hydrochloride Injection Sales by Application (2027-2032) & (K Units) Table 58. Global Esketamine Hydrochloride Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Esketamine Hydrochloride Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Esketamine Hydrochloride Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Esketamine Hydrochloride Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 63. North America Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 65. Europe Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 69. Latin America Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Jiangsu Hengrui Medicine Company Information Table 73. Jiangsu Hengrui Medicine Business Overview Table 74. Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Product Portfolio Table 76. Jiangsu Hengrui Medicine Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Esketamine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Pfizer Esketamine Hydrochloride Injection Product Portfolio Table 81. Pfizer Recent Development Table 82. Laboratoires CDM Lavoisier Company Information Table 83. Laboratoires CDM Lavoisier Business Overview Table 84. Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Product Portfolio Table 86. Laboratoires CDM Lavoisier Recent Development Table 87. North America Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 88. North America Esketamine Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 89. North America Esketamine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 90. North America Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units) Table 91. North America Esketamine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 92. North America Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 93. North America Esketamine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 94. North America Esketamine Hydrochloride Injection Market Share by Country (2021-2026) Table 95. North America Esketamine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 96. North America Esketamine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 97. Europe Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 98. Europe Esketamine Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 99. Europe Esketamine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 100. Europe Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units) Table 101. Europe Esketamine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 102. Europe Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. Europe Esketamine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 104. Europe Esketamine Hydrochloride Injection Market Share by Country (2021-2026) Table 105. Europe Esketamine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. Europe Esketamine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Esketamine Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 109. Asia-Pacific Esketamine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 110. Asia-Pacific Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units) Table 111. Asia-Pacific Esketamine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Esketamine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 114. Asia-Pacific Esketamine Hydrochloride Injection Market Share by Country (2021-2026) Table 115. Asia-Pacific Esketamine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Asia-Pacific Esketamine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 117. Latin America Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Latin America Esketamine Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 119. Latin America Esketamine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 120. Latin America Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units) Table 121. Latin America Esketamine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 122. Latin America Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Latin America Esketamine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 124. Latin America Esketamine Hydrochloride Injection Market Share by Country (2021-2026) Table 125. Latin America Esketamine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Latin America Esketamine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Esketamine Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 129. Middle East and Africa Esketamine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 130. Middle East and Africa Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units) Table 131. Middle East and Africa Esketamine Hydrochloride Injection Sales Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Esketamine Hydrochloride Injection Market Size by Country (2021-2026) & (US$ Million) Table 134. Middle East and Africa Esketamine Hydrochloride Injection Market Share by Country (2021-2026) Table 135. Middle East and Africa Esketamine Hydrochloride Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Middle East and Africa Esketamine Hydrochloride Injection Market Share Forecast by Country (2027-2032) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Esketamine Hydrochloride Injection Distributors List Table 140. Esketamine Hydrochloride Injection Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Esketamine Hydrochloride Injection Image Figure 2. Global Esketamine Hydrochloride Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Esketamine Hydrochloride Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Esketamine Hydrochloride Injection Sales (2021-2032) & (K Units) Figure 5. 2ml:50mg Image Figure 6. Global 2ml:50mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 5ml:25mg Image Figure 8. Global 5ml:25mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Esketamine Hydrochloride Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Esketamine Hydrochloride Injection Market Share by Type 2025 VS 2032 Figure 13. North America Esketamine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Esketamine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Esketamine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Esketamine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Esketamine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Esketamine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Esketamine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Esketamine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Esketamine Hydrochloride Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Esketamine Hydrochloride Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Esketamine Hydrochloride Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals and Clinics Image Figure 26. Global Hospitals and Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 27. Ambulatory Surgery Centers Image Figure 28. Global Ambulatory Surgery Centers Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Esketamine Hydrochloride Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Esketamine Hydrochloride Injection Market Share by Application 2025 VS 2032 Figure 31. North America Esketamine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Esketamine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Esketamine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Esketamine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Esketamine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Esketamine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Esketamine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Esketamine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Esketamine Hydrochloride Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Esketamine Hydrochloride Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Esketamine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Esketamine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Esketamine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Esketamine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Esketamine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Esketamine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Esketamine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Esketamine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Esketamine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Esketamine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Esketamine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Esketamine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Esketamine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Esketamine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Esketamine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Esketamine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Esketamine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Esketamine Hydrochloride Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Esketamine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Esketamine Hydrochloride Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Esketamine Hydrochloride Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Esketamine Hydrochloride Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 2ml:50mg
  • 5ml:25mg
  • Others
Applications
  • Hospitals and Clinics
  • Ambulatory Surgery Centers
Companies covered
  • Jiangsu Hengrui Medicine
  • Pfizer
  • Laboratoires CDM Lavoisier

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Esketamine Hydrochloride Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Esketamine Hydrochloride Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Esketamine Hydrochloride Injection Market by Type
  6. 1.3.1 2ml:50mg
  7. 1.3.2 5ml:25mg
  8. 1.3.3 Others
  9. 1.4 Global Esketamine Hydrochloride Injection Market Size by Type
  10. 1.4.1 Global Esketamine Hydrochloride Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Esketamine Hydrochloride Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Esketamine Hydrochloride Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Esketamine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Esketamine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Esketamine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Esketamine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Esketamine Hydrochloride Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Esketamine Hydrochloride Injection Industry Trends
  2. 2.2 Esketamine Hydrochloride Injection Industry Drivers
  3. 2.3 Esketamine Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Esketamine Hydrochloride Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Esketamine Hydrochloride Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Esketamine Hydrochloride Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Esketamine Hydrochloride Injection Price (2021-2026)
  4. 3.4 Global Esketamine Hydrochloride Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Esketamine Hydrochloride Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Esketamine Hydrochloride Injection Company, Product Type & Application
  7. 3.7 Global Esketamine Hydrochloride Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Esketamine Hydrochloride Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Esketamine Hydrochloride Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Esketamine Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Esketamine Hydrochloride Injection Regional Status and Outlook
  1. 4.1 Global Esketamine Hydrochloride Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Esketamine Hydrochloride Injection Historic Market Size by Region
  3. 4.2.1 Global Esketamine Hydrochloride Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Esketamine Hydrochloride Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Esketamine Hydrochloride Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Esketamine Hydrochloride Injection Forecasted Market Size by Region
  7. 4.3.1 Global Esketamine Hydrochloride Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Esketamine Hydrochloride Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Esketamine Hydrochloride Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Esketamine Hydrochloride Injection by Application
  1. 5.1 Esketamine Hydrochloride Injection Market by Application
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Ambulatory Surgery Centers
  4. 5.2 Global Esketamine Hydrochloride Injection Market Size by Application
  5. 5.2.1 Global Esketamine Hydrochloride Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Esketamine Hydrochloride Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Esketamine Hydrochloride Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Esketamine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Esketamine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Esketamine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Esketamine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Esketamine Hydrochloride Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Jiangsu Hengrui Medicine
  2. 6.1.1 Jiangsu Hengrui Medicine Company Information
  3. 6.1.2 Jiangsu Hengrui Medicine Business Overview
  4. 6.1.3 Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Product Portfolio
  6. 6.1.5 Jiangsu Hengrui Medicine Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Esketamine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Esketamine Hydrochloride Injection Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Laboratoires CDM Lavoisier
  14. 6.3.1 Laboratoires CDM Lavoisier Company Information
  15. 6.3.2 Laboratoires CDM Lavoisier Business Overview
  16. 6.3.3 Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Product Portfolio
  18. 6.3.5 Laboratoires CDM Lavoisier Recent Developments
7 North America by Country
  1. 7.1 North America Esketamine Hydrochloride Injection Sales by Country
  2. 7.1.1 North America Esketamine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Esketamine Hydrochloride Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Esketamine Hydrochloride Injection Market Size by Country
  6. 7.2.1 North America Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Esketamine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Esketamine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Esketamine Hydrochloride Injection Sales by Country
  2. 8.1.1 Europe Esketamine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Esketamine Hydrochloride Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Esketamine Hydrochloride Injection Market Size by Country
  6. 8.2.1 Europe Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Esketamine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Esketamine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Esketamine Hydrochloride Injection Sales by Country
  2. 9.1.1 Asia-Pacific Esketamine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Esketamine Hydrochloride Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Esketamine Hydrochloride Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Esketamine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Esketamine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Esketamine Hydrochloride Injection Sales by Country
  2. 10.1.1 South America Esketamine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Esketamine Hydrochloride Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Esketamine Hydrochloride Injection Market Size by Country
  6. 10.2.1 South America Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Esketamine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Esketamine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Esketamine Hydrochloride Injection Sales by Country
  2. 11.1.1 Middle East and Africa Esketamine Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Esketamine Hydrochloride Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Esketamine Hydrochloride Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Esketamine Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Esketamine Hydrochloride Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Esketamine Hydrochloride Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Esketamine Hydrochloride Injection Value Chain Analysis
  2. 12.1.1 Esketamine Hydrochloride Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Esketamine Hydrochloride Injection Production Mode & Process
  7. 12.2 Esketamine Hydrochloride Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Esketamine Hydrochloride Injection Distributors
  10. 12.2.3 Esketamine Hydrochloride Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst